Please try another search
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. Its clinical-stage pipeline includes AVTX-002, AVTX-008, and AVTX-803 programs. AVTX-002 is an Anti-LIGHT monoclonal antibody for treatment of non-eosinophilic asthma, Crohn’s Disease, and COVID-19 acute respiratory distress syndromes. AVTX-008 is a fully human B and T lymphocyte attenuator (BTLA) agonist fusion protein that is being evaluated for several immune dysregulation disorders. AVTX-803 is a monosaccharide therapy for the treatment of leukocyte adhesion deficiency type II (LAD II), which is a congenital disorder of glycosylation (CDG).
Name | Age | Since | Title |
---|---|---|---|
Philip P. Gutry | 48 | 2015 | Independent Director |
Anne B. Young | - | - | Member of Scientific Advisory Board |
Ronald T. Borchardt | - | - | Member of Scientific Advisory Board |
Gunnar Magnus Severus Modee Persson | 62 | 2012 | Lead Independent Director |
Robert H. Lenox | - | - | Member of Scientific Advisory Board |
Dennis C. Liotta | 74 | - | Member of Scientific Advisory Board |
Sol J. Barer | 75 | 2020 | Special Advisor & Strategic Advisory Board |
Garry A. Neil | 68 | 2020 | Chairman of the Board, President & CEO |
Gilla Kaplan | 75 | 2020 | Independent Director |
June S. Almenoff | 65 | 2021 | Independent Director |
Mitchell Chan | 41 | 2021 | Independent Director |
Barbara S. Slusher | 58 | - | Founder and Member of Scientific Advisory Board |
Solomon H. Snyder | 84 | - | Founder and Chairman of Scientific Advisory Board |
Jonathan Goldman | - | 2024 | Independent Director |
Aaron Kantoff | 38 | 2024 | Independent Director |
Samantha Scollard Truex | 53 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review